Product Categories
Country: | China |
---|---|
Tel: | 028-028-88457210 |
Mobile: | 18123311397 |
E-mail: | |
QQ: | |
Skype: | Chat Now! |
Product Name | MF | CAS | Details |
---|
Regorafenib impurity | C14H9ClF4N2O2 | 2243399-56-4 | Details |
EZLA-ZZC-0/EZLA-S1 | C8H7BrFNO | 749927-69-3 | Details |
4-amino-2-fluoro-N-methylbenzamide | C8H9FN2O | 915087-25-1 | Details |
EP-E;IpratropiuM BroMide IMpurity E | C19H27NO3 | 183626-76-8 | Details |
SL-CLYG;Sorafenib related coMpound 8 | C21H16ClF3N4O3 | 1431697-81-2 | Details |
Enzalutamide Impurity 7 | C21H18F4N4O3S | 2030242-21-6 | Details |
4-(Isopropylamino)-2-(trifluoromethyl)benzonitrile | C11H11F3N2 | 864286-45-3 | Details |
METHOXY-PHENYL-ACETIC ACID METHYL ESTER | C10H12O3 | 3558-61-0 | Details |
API-ZA01/M2-2J | C27H22F2N6O5 | 2438857-80-6 | Details |
3-methoxy-3-oxo-2-phenylpropanoic acid | C10H10O4 | 33315-63-8 | Details |
SM3-ZA02/RG-D;Regorafenib iMpurity | C14H9ClF4N2O2 | 1333390-56-9 | Details |
Regorafenib impurity H | C15H14FN3O3 | 2141961-84-2 | Details |
2-CHLORO-6-(TRIFLUOROMETHYL)PHENYL | C8H3ClF3NO | 16583-76-9 | Details |
Sorafenib impurity 14/Isopropyl (4-((2-(methylcarbamoyl)pyridin-4-yl)oxy)phenyl)carbamate | C17H19N3O4 | 2206827-14-5 | Details |
API-ZA07;3,4-BIS CTF- CARBOMYLAMINE PMA REGORAFENIB | C35H23Cl2F7N6O5 | 2098799-13-2 | Details |
2-Pyridinecarboxamide, 1,4-dihydro-N-methyl-4-oxo- | C7H8N2O2 | 1061231-84-2 | Details |
APOATROPINE | C17H21NO2 | 500-55-0 | Details |
D3-EZ-S2 | C9H3F3N2S | 143782-23-4 | Details |
2-Pyridinecarboxamide,N-methyl-(9CI) | C7H8N2O | 6144-78-1 | Details |
NA | 1489977-24-8 | Details |
EZLA-2JXA | C22H18F4N4O2S | 1443331-78-9 | Details |
APLA-COOH | C20H12F4N4O3S | 1332391-04-4 | Details |
2-fluoro-4-hydroxy-N-methylbenzamide | C8H8FNO2 | 1243392-80-4 | Details |
4-(4-Aminophenoxy)-N-methylpicolinamide | C13H13N3O2 | 284462-37-9 | Details |
Atropic acid | C9H8O2 | 492-38-6 | Details |
Regorafenib;BAY 73-4506 | C21H15ClF4N4O3 | 755037-03-7 | Details |
Tropic acid | C9H10O3 | 529-64-6 | Details |
4-(4-(3-(4-chloro-3-(trifluoroMethyl)phenyl)ureido)-3-fluorophenoxy)-2-(MethylcarbaMoyl)pyridine 1-oxide | C21H15ClF4N4O4 | 835621-11-9 | Details |
Sorafenib Impurity 6 | C21H17F3N4O3 | 1285533-84-7 | Details |
4-bromo-N-methylpicolinamide | C7H7BrN2O | 1209459-88-0 | Details |
AI-ZA04;4-Chloro-alpha,alpha,alpha-trifluoro-m-toluidine | C7H5ClF3N | 320-51-4 | Details |
Atropine Impurity 5 | C18H25NO2 | 88607-15-2 | Details |
YB-S2-COOH;Anisodine Impurity 4 | C9H8O3 | 59216-85-2 | Details |
EZ-396 | C17H12F4N4OS | 1798807-39-2 | Details |
ETHYL 4-CHLORO-3-TRIFLUOROMETHYLCARBANILATE | C10H9ClF3NO2 | 18585-06-3 | Details |
YB-S2;METHYL A-FORMYLPHENYLACETATE | C10H10O3 | 5894-79-1 | Details |
Sorafenib impurity N/1-(4-chloro-3-(trifluoromethyl)phenyl)urea | C8H6ClF3N2O | 343247-69-8 | Details |
2-fluoro-N,N-dimethyl-4-nitro-benzamide | C9H9FN2O3 | 1187368-66-6 | Details |
N-methyl-4-phenoxypyridine-2-carboxamide | C13H12N2O2 | 2004659-85-0 | Details |
YB-YM2; Ipratropium Bromide Impurity 12 | C20H29Br2NO3 | 60233-19-4 | Details |
Sorafenib impurity 16/Ethyl (4-((2-(methylcarbamoyl)pyridin-4-yl)oxy)phenyl)carbamate | C16H17N3O4 | 2206827-12-3 | Details |
YB-YM1;8-isopropyl-8-azabicyclo[3.2.1]oct-3-yl endo-(±)-formylphenylacetate | C19H25NO3 | 22235-74-1 | Details |
2-Fluoro-4-Hydroxyaniline | C6H6FNO | 1009816-75-4 | Details |
4-(4-AMINO-3-FLUOROPHENOXY)-N-METHYLPICOLINAMIDE | C13H12FN3O2 | 757251-39-1 | Details |
YB-ZZF;IpratropiuM BroMide IMpurity F (Mixture of DiastereoMers) | C20H29Br2NO3 | 17812-46-3 | Details |
AP-API-XA | C20H13F4N5O2S | 1332391-11-3 | Details |
EZ-S3-2J-O | C17H8F6N4O | 1895865-11-8 | Details |
INDEX NAME NOT YET ASSIGNED | C22H12Cl2F7N3O3 | 2518416-73-2 | Details |
Noratropine | C16H21NO3 | 16839-98-8 | Details |
Methyl 4-bromo-2-fluorobenzoate | C8H6BrFO2 | 179232-29-2 | Details |
DL-TROPIC ACID | C9H10O3 | 552-63-6 | Details |
6-Chloro-N-methylpyridine-2-carboxamide | C7H7ClN2O | 845306-04-9 | Details |
Ethyl Tropic Acid | C11H14O3 | 3979-14-4 | Details |
RG-368;Regorafenib Impurity 10 | C19H17FN4O3 | 2098799-12-1 | Details |
API-ZA05/API-ZA05/RG-F | C21H16F4N4O3 | 2188236-16-8 | Details |
EZLA-API | C21H17F3N4O2S | 915087-16-0 | Details |
Regorafenib Impurity 13 | C14H14N2O | 2909-32-2 | Details |
Sorafenib Impurity 6 | C27H23N5O6 | 2204442-52-2 | Details |
1,2-dimethylpiperidine | C7H15N | 671-36-3 | Details |
YB-M2 | C19H27NO3 | 22235-81-0 | Details |
Benzamide, 4-[[[[4-cyano-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-2-fluoro-N-methyl- | C17H12F4N4O2 | 1351185-73-3 | Details |
4-Bromo-2-fluorobenzoic acid | C7H4BrFO2 | 112704-79-7 | Details |
N-Desmethyl Regorafenib N-Oxide (M5 Metabolite) | C20H13ClF4N4O4 | 835621-12-0 | Details |
TICAGRELOR | C14H14N4O3 | 1129683-88-0 | Details |
SL-M2-2J;Sorafenib Impurity 3 | C27H24N6O5 | 284670-98-0 | Details |
VORSMCHHJRVORT-UHFFFAOYSA-N | C19H27NO3 | 793603-45-9 | Details |
RG-S1-XA; 4-Chloropyridine-2-carboxamide | C6H5ClN2O | 99586-65-9 | Details |
ATP-M1;Benzeneacetic acid, α-formyl-, (3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester | C17H21NO3 | 22226-37-5 | Details |
(endo,anti)-(±)-3-(3-hydroxy-1-oxo-2-phenylpropoxy)-8-isopropyl-8-methyl-8-azoniabicyclo[3.2.1]octane bromide | C20H30BrNO3 | 58073-59-9 | Details |
Apalutamide Desfluoro Impurity | C21H16F3N5O2S | 1332389-57-7 | Details |
A-(HYDROXYMETHYL)BENZENACETIC ACID METHYL ESTER | C10H12O3 | 3967-53-1 | Details |
N-[4-Chloro-3-(trifluoromethyl)phenyl]-N'-(4-hydroxyphenyl)urea | C14H10ClF3N2O2 | 1129683-83-5 | Details |
EZLA:S3-2J-S | C17H8F6N4S | 1839619-50-9 | Details |
CPI-203 | C8H3ClF3NO | 88330-63-6 | Details |
D3-EZLA-M1 | C21H15F4N3O3S | 1802242-43-8 | Details |
API-ZA02/RG-L;API-ZA02/RG-L(EZLA-S3-2J-O); FLUCOFURON | C15H8Cl2F6N2O | 370-50-3 | Details |
2-CHLORO-4-(TRIFLUOROMETHYL)PHENYL | C8H3ClF3NO | 51488-22-3 | Details |
Ipratropium Bromide EP Impurity F Bromide | C20H28BrNO2 | 60018-35-1 | Details |
Regorafenib Impurities67 | C16H16FN3O4 | 2514957-39-0 | Details |
8-isopropyl-8-azabicyclo[3.2.1]octan-3-one | C10H17NO | 3423-28-7 | Details |
N-isopropyltropinium | C11H22BrNO | 58005-18-8 | Details |
4-CYANO-3-(TRIFLUOROMETHYL)ACETANILIDE | C10H7F3N2O | 97760-99-1 | Details |
Ipratropium bromide monohydrate | C20H32BrNO4 | 66985-17-9 | Details |
Apalutamide | C21H15F4N5O2S | 956104-40-8 | Details |
EZLA-M1 | C12H15FN2O3 | 1289942-66-0 | Details |
4-Amino-2-(trifluoromethyl)benzonitrile | C8H5F3N2 | 654-70-6 | Details |
SM1-ZA01 | C9H7ClF3NO | 348-90-3 | Details |
EZLA-API-ZZA | C10H7F3N2OS | 1895865-10-7 | Details |
SORAFENIB N-OXIDE | C21H16ClF3N4O4 | 583840-03-3 | Details |
YB-API | C20H30NO3.Br | 22254-24-6 | Details |
Benzamide, N-[[[4-cyano-3-(trifluoromethyl)phenyl]amino]thioxomethyl]- | C16H10F3N3OS | 1895865-08-3 | Details |
Urea, N'-[4-chloro-3-(trifluoromethyl)phenyl]-N,N-dimethyl- | C10H10ClF3N2O | 2711-18-4 | Details |
SL-M2-TA-COOH;4-phenoxypyridine-2-carboxylic acid | C12H9NO3 | 99970-10-2 | Details |
RG-491; INDEX NAME NOT YET ASSIGNED | C25H19F2N5O4 | 2518234-85-8 | Details |
Carbamothioic acid, N-[4-cyano-3-(trifluoromethyl)phenyl]-, O-ethyl ester | C11H9F3N2OS | 2088914-59-2 | Details |
2-Pyridinecarboxamide, 4-chloro-N-(2-fluoro-4-hydroxyphenyl)- | C12H8ClFN2O2 | 1798046-84-0 | Details |
Thiourea, N-[4-cyano-3-(trifluoromethyl)phenyl]- | C9H6F3N3S | 1415552-04-3 | Details |
Benzene, 2-chloro-4-isocyanato-1-(trifluoromethyl)- | C8H3ClF3NO | 39893-50-0 | Details |
Benzamide, 4-[7-[6-cyano-5-(trifluoromethyl)-3-pyridinyl]-6,8-dithioxo-5,7-diazaspiro[3.4]oct-5-yl]-2-fluoro-N-methyl- | C21H15F4N5OS2 | 2649802-40-2 | Details |
EZ-437 | C21H19F4N3O3 | 2463603-98-5 | Details |
Product Total: Product Page: | ||||
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 |